While the connection has been reported for more than three decades, there is still a large gap in understanding and addressing it from a practical multidisciplinary point of view and awareness is essential, especially since the timeline perspective includes an early CLA identification before the recognition of the thyroid cancer in subjects who are not already confirmed with RET pathogenic variants or they are not under endocrine surveillance protocols. This evidence concerns the gene RET and thyroid gland carcinoma.